Sen. Tim Scott of South Carolina announced on May 22 that he will seek the Republican nomination for president in 2024. We reviewed his speech — and an exclusive NBC News interview he did shortly after — and found that he made a few claims that were false, misleading or lacked important context.
Former President Donald Trump’s town hall event felt like a lightning round of false and misleading claims — most of which we’ve heard before — on voter fraud, immigration, classified documents and more.
In recent years, Democrats in Congress have introduced a bill that would bar states from prohibiting abortion after a fetus is viable outside the womb in cases where the patient’s life or health is at risk. Republicans claim that the bill would allow abortion on demand “up to the moment of birth.” Democrats counter that’s not what they support.
A quarterly update of statistical measures of the president’s time in office.
President Joe Biden announced on April 25 that he would run for reelection in the 2024 campaign. In his video announcement and a speech later that day to a union group, Biden repeated several claims we’ve fact-checked before.
More than half of abortions in the U.S. are medication abortions, done early in pregnancies. But federal court rulings have raised questions about the future availability of mifepristone, the first of the two-drug combination used in those abortions. Here we answer questions about the court rulings, mifepristone and what may happen next.
In a speech from Mar-a-Lago hours after pleading not guilty to criminal charges in Manhattan, and in social media posts, former President Donald Trump has said the case against him is unfair. Here, we explain his attacks on the prosecutor, judge and venue.
In his first 2024 campaign rally in Waco, Texas, and in a recent interview, former President Donald Trump repeated many claims we’ve fact-checked before — but he also made new false and unsupported statements.
Nearly all children get sick from respiratory syncytial virus, or RSV, by the age of 2, and last year, there was a notable surge in RSV-associated hospitalizations. But the Food and Drug Administration is now considering approval of a vaccine and a monoclonal antibody aimed at protecting infants from this common virus.
This year, the Food and Drug Administration will consider several applications for vaccines and a monoclonal antibody to prevent respiratory syncytial virus, or RSV, illness. We’ll go through some common questions about RSV and the potential vaccines for older adults in this story.